Perspectives on Outsourcing

Mar 01, 2018
BioPharm International
Development and adoption of new technologies create challenges that may take years to resolve.
Jan 01, 2018
BioPharm International
The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
Dec 01, 2017
BioPharm International
In a productive year, 2017 was filled with acquisitions, facility expansions, and new biopharma technology.
Nov 01, 2017
BioPharm International
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.
Oct 01, 2017
BioPharm International
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
Sep 01, 2017
BioPharm International
Innovation speeds discovery, drives down costs, and improves productivity.
Aug 01, 2017
BioPharm International
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Jul 01, 2017
BioPharm International
How has the bio/pharmaceutical contract manufacturing industry evolved and changed over the years and what does the future hold?
Jun 01, 2017
BioPharm International
Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.
May 01, 2017
BioPharm International
CMOs may be gaining as strategic partners to large bio/pharma companies, but they have a much harder path to navigate.
native1_300x100
lorem ipsum